DOI QR코드

DOI QR Code

Long-Term Clinical Effects of Carotid Intraplaque Neovascularization in Patients with Coronary Artery Disease

  • Hyemoon Chung (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University) ;
  • Bu Yong Kim (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University) ;
  • Hyun Soo Kim (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University) ;
  • Hyung Oh Kim (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University) ;
  • Jung Myung Lee (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University) ;
  • Jong Shin Woo (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University) ;
  • Jin Bae Kim (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University) ;
  • Woo-Shik Kim (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University) ;
  • Kwon Sam Kim (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University) ;
  • Weon Kim (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University)
  • Received : 2019.07.22
  • Accepted : 2020.02.09
  • Published : 2020.07.01

Abstract

Objective: To investigate the predictive value of intraplaque neovascularization (IPN) for cardiovascular outcomes. Materials and Methods: We evaluated 217 patients with coronary artery disease (CAD) (158 men; mean age, 68 ± 10 years) with a maximal carotid plaque thickness ≥ 1.5 mm for the presence of IPN using contrast-enhanced ultrasonography. We compared patients with (n = 116) and without (n = 101) IPN during the follow-up period and investigated the predictors of major adverse cardiovascular events (MACE), including cardiac death, myocardial infarction, coronary artery revascularization, and transient ischemic accident/stroke. Results: During the mean follow-up period of 995 ± 610 days, the MACE rate was 6% (13/217). Patients with IPN had a higher maximal thickness than those without IPN (2.86 ± 1.01 vs. 2.61 ± 0.84 mm, p = 0.046). Common carotid artery-peak systolic velocity, left ventricular mass index (LVMI), and ventricular-vascular coupling index were significantly correlated with MACE. However, on multivariate Cox regression analysis, increased LVMI was independently related to MACE (p < 0.05). The presence of IPN could not predict MACE. Conclusion: The presence of IPN was related to a higher plaque thickness but could not predict cardiovascular outcomes better than conventional clinical factors in patients with CAD.

Keywords

Acknowledgement

We thank the study participants for making this study possible.

References

  1. Hellings WE, Peeters W, Moll FL, Piers SR, van Setten J, Van der Spek PJ, et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010;121:1941-1950
  2. Handa N, Matsumoto M, Maeda H, Hougaku H, Kamada T. Ischemic stroke events and carotid atherosclerosis. Results of the Osaka follow-up study for ultrasonographic assessment of carotid atherosclerosis (the OSACA Study). Stroke 1995;26:1781-1786
  3. Doyle B, Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J Am Coll Cardiol 2007;49:2073-2080
  4. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003;108:1664-1672
  5. Owen DR, Shalhoub J, Miller S, Gauthier T, Doryforou O, Davies AH, et al. Inflammation within carotid atherosclerotic plaque: assessment with late-phase contrast-enhanced US. Radiology 2010;255:638-644
  6. Magnoni M, Ammirati E, Moroni F, Norata GD, Camici PG. Impact of cardiovascular risk factors and pharmacologic treatments on carotid intraplaque neovascularization detected by contrast-enhanced ultrasound. J Am Soc Echocardiogr 2019;32:113-120.e6
  7. Staub D, Patel MB, Tibrewala A, Ludden D, Johnson M, Espinosa P, et al. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke 2010;41:41-47
  8. Staub D, Schinkel AF, Coll B, Coli S, van der Steen AF, Reed JD, et al. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 2010;3:761-771
  9. Demeure F, Bouzin C, Roelants V, Bol A, Verhelst R, Astarci P, et al. Head-to-head comparison of inflammation and neovascularization in human carotid plaques: implications for the imaging of vulnerable plaques. Circ Cardiovasc Imaging 2017;10. pii: e005846
  10. Her AY, Kim JY, Choi EY, Kim SA, Jae RS, Shim CY, et al. Value of ventricular stiffness index and ventriculoarterial interaction in patients with nonischemic dilated cardiomyopathy. Circ J 2009;73:1683-1690
  11. Choi EY, Choi BW, Kim SA, Rhee SJ, Shim CY, Kim YJ, et al. Patterns of late gadolinium enhancement are associated with ventricular stiffness in patients with advanced non-ischaemic dilated cardiomyopathy. Eur J Heart Fail 2009;11:573-580
  12. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr 2008;21:93-111; quiz 189-190
  13. Kim HS, Woo JS, Kim BY, Jang HH, Hwang SJ, Kwon SJ, et al. Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid artery. Atherosclerosis 2014;233:579-583
  14. Pelisek J, Well G, Reeps C, Rudelius M, Kuehnl A, Culmes M, et al. Neovascularization and angiogenic factors in advanced human carotid artery stenosis. Circ J 2012;76:1274-1282
  15. Purushothaman KR, Purushothaman M, Muntner P, Lento PA, O'Connor WN, Sharma SK, et al. Inflammation, neovascularization and intra-plaque hemorrhage are associated with increased reparative collagen content: implication for plaque progression in diabetic atherosclerosis. Vasc Med 2011;16:103-108
  16. Willems S, Vink A, Bot I, Quax PH, de Borst GJ, de Vries JP, et al. Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events. Eur Heart J 2013;34:3699-3706
  17. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115-126
  18. D'Oria M, Chiarandini S, Pipitone MD, Fisicaro M, Calvagna C, Bussani R, et al. Contrast enhanced ultrasound (CEUS) is not able to identify vulnerable plaques in asymptomatic carotid atherosclerotic disease. Eur J Vasc Endovasc Surg 2018;56:632-642
  19. van den Oord SC, Akkus Z, Renaud G, Bosch JG, van der Steen AF, Sijbrands EJ, et al. Assessment of carotid atherosclerosis, intraplaque neovascularization, and plaque ulceration using quantitative contrast-enhanced ultrasound in asymptomatic patients with diabetes mellitus. Eur Heart J Cardiovasc Imaging 2014;15:1213-1218
  20. Calcagno C, Ramachandran S, Izquierdo-Garcia D, Mani V, Millon A, Rosenbaum D, et al. The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. Eur J Nucl Med Mol Imaging 2013;40:1884-1893
  21. Song Y, Dang Y, Dang LL, Zhao C, Zheng J, Feng J, et al. Association between intraplaque neovascularization assessed by contrast-enhanced ultrasound and the risk of stroke. Clin Radiol 2020;75:70-75